Mayne Pharma dives on US deal announcement
MELBOURNE: Shares in ASX-listed drug company Mayne Pharma have dived 12.5 per cent ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
FEATURED
US casinos group Bally’s joins Star Entertainment scramble
Third executive quits as company battles money laundering case
SkyCity Adelaide casino recruiting 140 jobs amid ‘transformation’
Aristocrat shares hit after opposition to CEO incentive scheme
Tabcorp profit as McLachlan wields costs axe everywhere